Acquisition by Edelman Joseph of 100000 shares of Aldeyra at 5.84 subject to Rule 16b-3

ALDX Stock  USD 4.76  0.03  0.63%   
Slightly above 53% of Aldeyra's investor base is interested to short. The analysis of the overall investor sentiment regarding Aldeyra suggests that many traders are impartial. Aldeyra's investing sentiment can be driven by a variety of factors including economic data, Aldeyra's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Aldeyra Director . Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 100000 common stock at 5.84 of Aldeyra by Edelman Joseph on 24th of December 2024. This event was filed by Aldeyra with SEC on 2022-08-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Aldeyra's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Aldeyra's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Aldeyra Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Aldeyra can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Aldeyra Fundamental Analysis

We analyze Aldeyra's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aldeyra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aldeyra based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Aldeyra is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Aldeyra Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aldeyra stock to make a market-neutral strategy. Peer analysis of Aldeyra could also be used in its relative valuation, which is a method of valuing Aldeyra by comparing valuation metrics with similar companies.

Peers

Aldeyra Related Equities

BLRXBioLineRx   10.00   
0%
100.0%
CGEMCullinan Oncology   3.37   
0%
33.0%
PHATPhathom Pharmaceuticals   2.15   
0%
21.0%
ARDXArdelyx   1.31   
0%
13.0%
ETONEton Pharmaceuticals   1.28   
0%
12.0%
BPMCBlueprint Medicines   0.21   
0%
2.0%
DAWNDay One   0.16   
1.0%
0%
TVTXTravere Therapeutics   0.17   
1.0%
0%
ETNB89bio   0.63   
6.0%
0%
TARSTarsus Pharmaceuticals   0.74   
7.0%
0%
MCRBSeres Therapeutics   1.03   
10.0%
0%
GPCRStructure Therapeutics   1.05   
10.0%
0%
IBRXImmunitybio   1.50   
15.0%
0%
VRDNViridian Therapeutics   1.83   
18.0%
0%
TERNTerns Pharmaceuticals   2.19   
21.0%
0%
INZYInozyme Pharma   2.66   
26.0%
0%
XFORX4 Pharmaceuticals   4.92   
49.0%
0%
LYRALyra Therapeutics   5.56   
55.0%
0%
HOOKHookipa Pharma   6.40   
64.0%
0%
LXRXLexicon Pharmaceuticals   8.43   
84.0%
0%

Additional Tools for Aldeyra Stock Analysis

When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.